# First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness

> **NCT04485858** · NA · TERMINATED · sponsor: **CorNeat Vision Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Corneal Disease
- Corneal Opacity
- Corneal Injuries

## Interventions

- **DEVICE:** CorNeat KPro

## Key facts

- **NCT ID:** NCT04485858
- **Lead sponsor:** CorNeat Vision Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-03
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2024-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04485858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04485858, "First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT04485858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*